Calif ornia-Based Opiant Licenses Synthetic Cannabinoid Overdose Drug From Sanofi for $500,000 Cannabis, Life Science
Rakuten Aspyrian Closes $284 Million Series C Financing for Late-Stage Oncology Pipeline Life Science
Xynomic Pharmaceuticals Picks up Second Cancer Drug From Boehringer Ingelheim in $800 Million Deal Life Science